Semaglutide

The GLP-1 agonist studied for appetite regulation and glycemic control.

$195USD

Dose pen · 5mg · 0.88mL

Semaglutide is a synthetic analog of human glucagon-like peptide-1 (GLP-1) studied for its engagement of GLP-1 receptor pathways. Research suggests it may stimulate glucose-dependent insulin secretion, suppress glucagon release, and slow gastric emptying. Central nervous system studies have also examined GLP-1 receptor activity in hypothalamic appetite centers, a mechanism of interest for satiety and food-intake research. Intended for research purposes.

Shop now ← Back to shop

+Why It Works

Semaglutide is a synthetic analog of GLP-1 studied for its engagement of GLP-1 receptor pathways. Research suggests it stimulates glucose-dependent insulin secretion, suppresses glucagon release, and slows gastric emptying, with CNS studies also examining GLP-1 receptor activity in hypothalamic appetite centers relevant to satiety research.

+Key Benefits

Appetite Regulation — Engages hypothalamic GLP-1 pathways tied to satiety signaling.
Glycemic Control Support — Stimulates glucose-dependent insulin secretion.
Slower Gastric Emptying — Associated with prolonged fullness after meals.

+Who It's For

Weight-management focused individualsResearching GLP-1 pathway support for appetite regulation.

Glycemic control researchersInterested in insulin and glucagon signaling pathways.

Research Use Only. These products have not been evaluated or approved by the FDA for use as drugs, therapeutics, diagnostics, or dietary supplements, and are not intended for administration to humans or animals. No product description or mechanism-of-action information constitutes a health claim or therapeutic endorsement. Any clinical use is at the sole discretion of a licensed healthcare provider in compliance with applicable laws. Individual results may vary.